Chronic liver disorders (CLDs) affect roughly 844 million people worldwide, and result in the deaths of about two million people each year. RegeneVive recently conducted research pointing to the potential benefit of stem cell therapy in addressing this epidemic.
IMPORTANT! All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.
© 2025 – RegeneVive Health and Wellness | All rights reserved | Maintained by Driven Digital, LLC